composite methylene blue injection (Guizhou Tongjitang Pharmaceutical)
N/A
Report date: 2025/02/01 20:00:06
NME
Base Information
Drug Namecomposite methylene blue injection (Guizhou Tongjitang Pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesChina National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesChina National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A